Home LiteratureArticle Details
PMID: 15575065 Published · ppublish English Comment Letter

Hyperkalemia after the publication of RALES.

The New England journal of medicine ·Vol. 351 ·No. 23 ·2004-12-02 ·Pages 2448-50; author reply 2448-50

Goldfarb DS

Abstract

暂无摘要

MeSH Terms
Cause of Death Heart Failure/drug therapy Hospitalization Humans Hyperkalemia/chemically induced,mortality Mineralocorticoid Receptor Antagonists/adverse effects Spironolactone/adverse effects
Chemicals
Mineralocorticoid Receptor Antagonists Spironolactone
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Goldfarb David S
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
1533-4406
DOI
10.1056/NEJM200412023512320
Published
2004-12-02
Pages
2448-50; author reply 2448-50
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Corrections
CommentOn
PMID: 15295047
External Links
PubMed source DOI: 10.1056/NEJM200412023512320 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2